We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




PCR Technology Helps Detect Food Pathogens and Spoilage Microorganisms

By Labmedica staff writers
Posted on 28 Apr 2008
Advanced real-time polymerase chain reaction (PCR) technology is increasingly being used in the rapid detection of food pathogens and spoilage microorganisms. More...
The technique allows an exponential amplification of DNA from just a few to more than a billion copies in less than one hour. This enables a significant reduction in the time taken to achieve results in comparison with conventional cultivation techniques.

The increasing use of rapid food safety testing is receiving more and more attention. The major reason for this key trend is that the food industry requires quick and accurate results. Traditional microbiological methods are relatively slow and sometimes inaccurate in comparison to new molecular biologic techniques. Fast and reliable detection systems are therefore the method of choice.

Under its foodproof brand, Biotecon Diagnostics (Potsdam, Germany) has developed real-time PCR detection kits for Enterobacteriaceae plus Enterobacter sakazakii (new), Salmonella, Listeria, Campylobacter, Escherichia coli O157, among others. The range also comprises a unique kit for the screening of beer spoilage organisms as well as genetically modified organism (GMO) testing kits.

To enhance the worldwide launch of its food safety testing systems, Biotecon Diagnostics has formed a strategic marketing alliance with the globally operating Merck (Darmstadt, Germany). Merck sells the foodproof range that has been available in almost all countries of the world since January 1, 2008. More products are expected to be forthcoming later in the year.

Dr. Kornelia Berghof-Jaeger, CEO, Biotecon Diagnostics said, "In this alliance, Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.”

"For Merck KGaA, this partnership means a consequential advancement in order to underline our leading position in specialty chemicals, especially in analytical reagents and test kits,” commented Wolfgang E. Schmidt, head of microbiology, hygiene, and microscopy at Merck KGaA. "Our philosophy of highest quality demands is perfectly met by the solutions offered by Biotecon Diagnostics.”


Related Links:
Biotecon Diagnostics
Merck

New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.